241 results on '"Yam, Judy Wai-Ping"'
Search Results
2. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles
3. SAT-375 Proteomic analysis of plasma exosomes: a novel method to identify potential therapeutic targets for chronic hepatitis B
4. Actin-related protein 2/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis
5. The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma
6. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma
7. Reprogramming of central carbon metabolism in hepatocellular carcinoma
8. The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments.
9. LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors
10. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value
11. NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma.
12. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
13. Clathrin light chain A‐enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis
14. Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
15. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway
16. Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
17. Supplementary Materials and Methods, Supplementary Figures 1 through 8, and Supplementary Table 1 from Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma
18. Data from Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma
19. Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
20. Supplementary Figure 2 from Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression
21. Supplementary Figure 1 from Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression
22. Supplementary Figure 3 from Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression
23. Supplementary Figure 1 from Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma
24. From Exosome Biogenesis to Absorption: Key Takeaways for Cancer Research
25. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation
26. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
27. Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors
28. S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos
29. Dihydroartemisinin engages liver fatty acid binding protein and suppresses metastatic hepatocellular carcinoma growth
30. The importance of activated TMPRSS2 in the proviral role of small extracellular vesicles in SARS‐CoV‐2 infection
31. An update on the role of complement in hepatocellular carcinoma
32. Molecular Pathogenesis of Hepatocellular Carcinoma
33. Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
34. Recent advances in liquid biopsy in cancers: Diagnosis, disease state and treatment response monitoring
35. Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
36. Role of Small Extracellular Vesicles in Liver Diseases: Pathogenesis, Diagnosis, and Treatment
37. Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer
38. Liver cancer cells with nuclear MET overexpression release translation regulatory protein‐enriched extracellular vesicles exhibit metastasis promoting activity
39. ACE2‐enriched extracellular vesicles enhance infectivity of live SARS‐CoV‐2 virus
40. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma
41. Actin Related Protein 2/3 Complex Subunit 2-enriched extracellular vesicles drive liver cancer metastasis
42. The Role of Arginine Metabolism in Oral Tongue Squamous Cell Carcinoma
43. RPNs Levels are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
44. The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma
45. Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis
46. TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis
47. Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
48. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity
49. Tumour extracellular vesicle‐derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement‐dependent cytotoxicity of tumour cells
50. Transcriptional regulation of the promoter of the rat frizzled related protein gene by CREB
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.